Featured

Dr. Philip M Arlen to present at Immunõ 2026, September 24 – 30, 2026

Strattmont Group2026-09-15T15:36:44-04:00

Precision Biologics, Inc. CEO Philip M Arlen, MD will give a presentation at Immunõ 2026:...

Precision Biologics announces publication of article in science journal CANCERS, July 20, 2026

Strattmont Group2026-09-15T15:29:31-04:00

Precision Biologics announces that an article, entitled "Afinity Maturation and Characterization of the Novel Monoclonal...

Precision Biologics, Inc. CEO Philip M Arlen to give Keynote at 7th Ace Drug Discovery Summit, San Diego, CA

Strattmont Group2026-05-06T21:38:15-04:00

Precision Biologics, Inc. CEO Philip M Arlen, MD, will give a Keynote speech and present...

AACR 2026 Annual Meeting, San Diego, CA April 19, 2026

Strattmont Group2026-04-17T15:22:34-04:00

NEO-201-recognized truncated Car 1 O-glycans represent a new target for CAR-NK therapy in AML

Precision Biologics’ Collaborators at NHLBI/NIH and U Va to Reveal New AML Target for CAR-NK at American Association for Cancer Research (AACR) Annual Meeting on April 19th, 2026, San Diego, CA

Strattmont Group2026-04-17T15:26:23-04:00

Truncated Core 1 O-glycans recognized by Precision Biologics’ monoclonal antibody (mAb) NEO-201 are discovered as...

Precision Biologics Highlights New AML Target for CAR-NK Therapies

Strattmont Group2026-04-27T14:42:14-04:00

US-based Precision Biologics, a clinical stage biotechnology company, has announced new preclinical findings identifying a...

Precision Biologics, Inc. CEO to present at the online Antibody-Drug Conjugates MicroSummit conference, March 17th, 2026.

Strattmont Group2026-03-12T14:47:23-04:00

Philip M. Arlen, M.D., will present an online talk at the third and last session...

Precision Biologics featured in Pharma Device News article March 8, 2026

Strattmont Group2026-03-12T13:19:53-04:00

Precision Biologics' approach is the subject of an article in the current issue of trade...

Precision Biologics, Inc. CEO Philip M. Arlen, MD, to give presentation on monoclonal antibodies against tumor-specific targets at Festival of Biologics USA, San Diego Convention Center, San Diego, CA, March 4-5, 2026

Strattmont Group2026-03-02T14:01:34-05:00

Precision Biologics, Inc. CEO Philip M. Arlen, MD, will give a presentation on monoclonal antibodies...

Dr. Philip M Arlen to present Keynote at the 6th Ace Drug Discovery Summit, London, UK, February 19, 2026

Strattmont Group2026-02-17T18:44:05-05:00

Precision Biologics, Inc. CEO Philip M Arlen, MD will give a Keynote speech and present...